nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—CYP2C19—Progesterone—uterine cancer	0.124	0.196	CbGbCtD
Clobazam—ABCB1—Progesterone—uterine cancer	0.1	0.158	CbGbCtD
Clobazam—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0907	0.143	CbGbCtD
Clobazam—ABCB1—Dactinomycin—uterine cancer	0.0795	0.125	CbGbCtD
Clobazam—CYP3A4—Progesterone—uterine cancer	0.0601	0.0946	CbGbCtD
Clobazam—CYP2B6—Doxorubicin—uterine cancer	0.0597	0.094	CbGbCtD
Clobazam—ABCB1—Etoposide—uterine cancer	0.0449	0.0706	CbGbCtD
Clobazam—ABCB1—Doxorubicin—uterine cancer	0.0306	0.0482	CbGbCtD
Clobazam—CYP3A4—Etoposide—uterine cancer	0.0269	0.0423	CbGbCtD
Clobazam—CYP3A4—Doxorubicin—uterine cancer	0.0183	0.0289	CbGbCtD
Clobazam—Dry mouth—Progesterone—uterine cancer	0.00129	0.00367	CcSEcCtD
Clobazam—Confusional state—Progesterone—uterine cancer	0.00127	0.00362	CcSEcCtD
Clobazam—Infection—Progesterone—uterine cancer	0.00125	0.00357	CcSEcCtD
Clobazam—Nervous system disorder—Progesterone—uterine cancer	0.00124	0.00353	CcSEcCtD
Clobazam—Skin disorder—Progesterone—uterine cancer	0.00123	0.00349	CcSEcCtD
Clobazam—Hyperhidrosis—Progesterone—uterine cancer	0.00122	0.00347	CcSEcCtD
Clobazam—Blood disorder—Epirubicin—uterine cancer	0.00121	0.00346	CcSEcCtD
Clobazam—Anorexia—Progesterone—uterine cancer	0.0012	0.00343	CcSEcCtD
Clobazam—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.0034	CcSEcCtD
Clobazam—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00339	CcSEcCtD
Clobazam—Erythema multiforme—Dactinomycin—uterine cancer	0.00119	0.00338	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00337	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00118	0.00337	CcSEcCtD
Clobazam—Delirium—Epirubicin—uterine cancer	0.00118	0.00336	CcSEcCtD
Clobazam—Hypotension—Progesterone—uterine cancer	0.00118	0.00336	CcSEcCtD
Clobazam—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00332	CcSEcCtD
Clobazam—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.00328	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00115	0.00327	CcSEcCtD
Clobazam—Insomnia—Progesterone—uterine cancer	0.00114	0.00325	CcSEcCtD
Clobazam—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00324	CcSEcCtD
Clobazam—Dysphagia—Etoposide—uterine cancer	0.00114	0.00323	CcSEcCtD
Clobazam—Blood disorder—Doxorubicin—uterine cancer	0.00112	0.0032	CcSEcCtD
Clobazam—Somnolence—Progesterone—uterine cancer	0.00112	0.0032	CcSEcCtD
Clobazam—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00319	CcSEcCtD
Clobazam—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00319	CcSEcCtD
Clobazam—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00316	CcSEcCtD
Clobazam—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00315	CcSEcCtD
Clobazam—Decreased appetite—Progesterone—uterine cancer	0.0011	0.00312	CcSEcCtD
Clobazam—Delirium—Doxorubicin—uterine cancer	0.00109	0.00311	CcSEcCtD
Clobazam—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.0031	CcSEcCtD
Clobazam—Gastrointestinal disorder—Progesterone—uterine cancer	0.00109	0.0031	CcSEcCtD
Clobazam—Fatigue—Progesterone—uterine cancer	0.00109	0.0031	CcSEcCtD
Clobazam—Constipation—Progesterone—uterine cancer	0.00108	0.00307	CcSEcCtD
Clobazam—Dysarthria—Epirubicin—uterine cancer	0.00107	0.00305	CcSEcCtD
Clobazam—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00304	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00297	CcSEcCtD
Clobazam—Feeling abnormal—Progesterone—uterine cancer	0.00104	0.00296	CcSEcCtD
Clobazam—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00295	CcSEcCtD
Clobazam—Pneumonia—Etoposide—uterine cancer	0.00102	0.0029	CcSEcCtD
Clobazam—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.0029	CcSEcCtD
Clobazam—Infestation NOS—Etoposide—uterine cancer	0.00101	0.00288	CcSEcCtD
Clobazam—Infestation—Etoposide—uterine cancer	0.00101	0.00288	CcSEcCtD
Clobazam—Anaemia—Dactinomycin—uterine cancer	0.00101	0.00288	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.001	0.00286	CcSEcCtD
Clobazam—Urticaria—Progesterone—uterine cancer	0.001	0.00286	CcSEcCtD
Clobazam—Body temperature increased—Progesterone—uterine cancer	0.000998	0.00284	CcSEcCtD
Clobazam—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000994	0.00283	CcSEcCtD
Clobazam—Dysarthria—Doxorubicin—uterine cancer	0.000992	0.00283	CcSEcCtD
Clobazam—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000987	0.00281	CcSEcCtD
Clobazam—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000986	0.00281	CcSEcCtD
Clobazam—Leukopenia—Dactinomycin—uterine cancer	0.000978	0.00279	CcSEcCtD
Clobazam—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000978	0.00279	CcSEcCtD
Clobazam—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000942	0.00268	CcSEcCtD
Clobazam—Myalgia—Dactinomycin—uterine cancer	0.000931	0.00265	CcSEcCtD
Clobazam—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000909	0.00259	CcSEcCtD
Clobazam—Asthenia—Progesterone—uterine cancer	0.000906	0.00258	CcSEcCtD
Clobazam—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000904	0.00257	CcSEcCtD
Clobazam—Pruritus—Progesterone—uterine cancer	0.000893	0.00254	CcSEcCtD
Clobazam—Infection—Dactinomycin—uterine cancer	0.000886	0.00252	CcSEcCtD
Clobazam—Thrombocytopenia—Dactinomycin—uterine cancer	0.000873	0.00249	CcSEcCtD
Clobazam—Diarrhoea—Progesterone—uterine cancer	0.000864	0.00246	CcSEcCtD
Clobazam—Erythema multiforme—Etoposide—uterine cancer	0.000859	0.00245	CcSEcCtD
Clobazam—Anorexia—Dactinomycin—uterine cancer	0.00085	0.00242	CcSEcCtD
Clobazam—Eye disorder—Etoposide—uterine cancer	0.000849	0.00242	CcSEcCtD
Clobazam—Dizziness—Progesterone—uterine cancer	0.000835	0.00238	CcSEcCtD
Clobazam—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000821	0.00234	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000813	0.00231	CcSEcCtD
Clobazam—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000809	0.0023	CcSEcCtD
Clobazam—Vomiting—Progesterone—uterine cancer	0.000802	0.00229	CcSEcCtD
Clobazam—Rash—Progesterone—uterine cancer	0.000796	0.00227	CcSEcCtD
Clobazam—Dermatitis—Progesterone—uterine cancer	0.000795	0.00226	CcSEcCtD
Clobazam—Headache—Progesterone—uterine cancer	0.000791	0.00225	CcSEcCtD
Clobazam—Increased appetite—Epirubicin—uterine cancer	0.000784	0.00223	CcSEcCtD
Clobazam—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000783	0.00223	CcSEcCtD
Clobazam—Decreased appetite—Dactinomycin—uterine cancer	0.000775	0.00221	CcSEcCtD
Clobazam—Fatigue—Dactinomycin—uterine cancer	0.000769	0.00219	CcSEcCtD
Clobazam—Muscle spasms—Etoposide—uterine cancer	0.000761	0.00217	CcSEcCtD
Clobazam—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000756	0.00215	CcSEcCtD
Clobazam—Lethargy—Epirubicin—uterine cancer	0.000751	0.00214	CcSEcCtD
Clobazam—Nausea—Progesterone—uterine cancer	0.00075	0.00214	CcSEcCtD
Clobazam—Osteoarthritis—Epirubicin—uterine cancer	0.000736	0.0021	CcSEcCtD
Clobazam—Diplopia—Epirubicin—uterine cancer	0.000736	0.0021	CcSEcCtD
Clobazam—Feeling abnormal—Dactinomycin—uterine cancer	0.000735	0.00209	CcSEcCtD
Clobazam—Anaemia—Etoposide—uterine cancer	0.000731	0.00208	CcSEcCtD
Clobazam—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000727	0.00207	CcSEcCtD
Clobazam—Increased appetite—Doxorubicin—uterine cancer	0.000725	0.00207	CcSEcCtD
Clobazam—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000721	0.00205	CcSEcCtD
Clobazam—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00072	0.00205	CcSEcCtD
Clobazam—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000716	0.00204	CcSEcCtD
Clobazam—Leukopenia—Etoposide—uterine cancer	0.000708	0.00202	CcSEcCtD
Clobazam—Body temperature increased—Dactinomycin—uterine cancer	0.000705	0.00201	CcSEcCtD
Clobazam—Lethargy—Doxorubicin—uterine cancer	0.000695	0.00198	CcSEcCtD
Clobazam—Ataxia—Epirubicin—uterine cancer	0.000692	0.00197	CcSEcCtD
Clobazam—Cough—Etoposide—uterine cancer	0.00069	0.00197	CcSEcCtD
Clobazam—Osteoarthritis—Doxorubicin—uterine cancer	0.000681	0.00194	CcSEcCtD
Clobazam—Diplopia—Doxorubicin—uterine cancer	0.000681	0.00194	CcSEcCtD
Clobazam—Liver function test abnormal—Epirubicin—uterine cancer	0.00068	0.00194	CcSEcCtD
Clobazam—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000679	0.00193	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000669	0.0019	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000663	0.00189	CcSEcCtD
Clobazam—Confusional state—Etoposide—uterine cancer	0.000651	0.00185	CcSEcCtD
Clobazam—Muscular weakness—Epirubicin—uterine cancer	0.000649	0.00185	CcSEcCtD
Clobazam—Infection—Etoposide—uterine cancer	0.000641	0.00183	CcSEcCtD
Clobazam—Abdominal distension—Epirubicin—uterine cancer	0.000641	0.00182	CcSEcCtD
Clobazam—Ataxia—Doxorubicin—uterine cancer	0.000641	0.00182	CcSEcCtD
Clobazam—Asthenia—Dactinomycin—uterine cancer	0.00064	0.00182	CcSEcCtD
Clobazam—Asthma—Epirubicin—uterine cancer	0.000636	0.00181	CcSEcCtD
Clobazam—Dysphagia—Epirubicin—uterine cancer	0.000636	0.00181	CcSEcCtD
Clobazam—Thrombocytopenia—Etoposide—uterine cancer	0.000632	0.0018	CcSEcCtD
Clobazam—Eosinophilia—Epirubicin—uterine cancer	0.00063	0.00179	CcSEcCtD
Clobazam—Liver function test abnormal—Doxorubicin—uterine cancer	0.000629	0.00179	CcSEcCtD
Clobazam—Skin disorder—Etoposide—uterine cancer	0.000627	0.00179	CcSEcCtD
Clobazam—Hyperhidrosis—Etoposide—uterine cancer	0.000624	0.00178	CcSEcCtD
Clobazam—Anorexia—Etoposide—uterine cancer	0.000615	0.00175	CcSEcCtD
Clobazam—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000614	0.00175	CcSEcCtD
Clobazam—Bronchitis—Epirubicin—uterine cancer	0.000612	0.00174	CcSEcCtD
Clobazam—Diarrhoea—Dactinomycin—uterine cancer	0.00061	0.00174	CcSEcCtD
Clobazam—Hypotension—Etoposide—uterine cancer	0.000603	0.00172	CcSEcCtD
Clobazam—Muscular weakness—Doxorubicin—uterine cancer	0.000601	0.00171	CcSEcCtD
Clobazam—Abdominal distension—Doxorubicin—uterine cancer	0.000593	0.00169	CcSEcCtD
Clobazam—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000591	0.00168	CcSEcCtD
Clobazam—Dysphagia—Doxorubicin—uterine cancer	0.000589	0.00168	CcSEcCtD
Clobazam—Asthma—Doxorubicin—uterine cancer	0.000589	0.00168	CcSEcCtD
Clobazam—Eosinophilia—Doxorubicin—uterine cancer	0.000583	0.00166	CcSEcCtD
Clobazam—Weight increased—Epirubicin—uterine cancer	0.000579	0.00165	CcSEcCtD
Clobazam—Somnolence—Etoposide—uterine cancer	0.000574	0.00163	CcSEcCtD
Clobazam—Pneumonia—Epirubicin—uterine cancer	0.000571	0.00163	CcSEcCtD
Clobazam—Infestation NOS—Epirubicin—uterine cancer	0.000567	0.00162	CcSEcCtD
Clobazam—Infestation—Epirubicin—uterine cancer	0.000567	0.00162	CcSEcCtD
Clobazam—Drowsiness—Epirubicin—uterine cancer	0.000567	0.00162	CcSEcCtD
Clobazam—Vomiting—Dactinomycin—uterine cancer	0.000567	0.00162	CcSEcCtD
Clobazam—Bronchitis—Doxorubicin—uterine cancer	0.000566	0.00161	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000563	0.0016	CcSEcCtD
Clobazam—Rash—Dactinomycin—uterine cancer	0.000562	0.0016	CcSEcCtD
Clobazam—Decreased appetite—Etoposide—uterine cancer	0.000561	0.0016	CcSEcCtD
Clobazam—Gastrointestinal disorder—Etoposide—uterine cancer	0.000557	0.00159	CcSEcCtD
Clobazam—Fatigue—Etoposide—uterine cancer	0.000557	0.00159	CcSEcCtD
Clobazam—Constipation—Etoposide—uterine cancer	0.000552	0.00157	CcSEcCtD
Clobazam—Urinary tract infection—Epirubicin—uterine cancer	0.000552	0.00157	CcSEcCtD
Clobazam—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000547	0.00156	CcSEcCtD
Clobazam—Sweating—Epirubicin—uterine cancer	0.000544	0.00155	CcSEcCtD
Clobazam—Weight increased—Doxorubicin—uterine cancer	0.000536	0.00153	CcSEcCtD
Clobazam—Feeling abnormal—Etoposide—uterine cancer	0.000532	0.00152	CcSEcCtD
Clobazam—Nausea—Dactinomycin—uterine cancer	0.00053	0.00151	CcSEcCtD
Clobazam—Pneumonia—Doxorubicin—uterine cancer	0.000528	0.0015	CcSEcCtD
Clobazam—Infestation NOS—Doxorubicin—uterine cancer	0.000525	0.0015	CcSEcCtD
Clobazam—Infestation—Doxorubicin—uterine cancer	0.000525	0.0015	CcSEcCtD
Clobazam—Drowsiness—Doxorubicin—uterine cancer	0.000525	0.0015	CcSEcCtD
Clobazam—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000521	0.00148	CcSEcCtD
Clobazam—Urticaria—Etoposide—uterine cancer	0.000513	0.00146	CcSEcCtD
Clobazam—Body temperature increased—Etoposide—uterine cancer	0.00051	0.00145	CcSEcCtD
Clobazam—Urinary tract infection—Doxorubicin—uterine cancer	0.00051	0.00145	CcSEcCtD
Clobazam—Sweating—Doxorubicin—uterine cancer	0.000503	0.00143	CcSEcCtD
Clobazam—SLC6A11—NRF2 pathway—NFE2L2—uterine cancer	0.0005	0.0361	CbGpPWpGaD
Clobazam—Visual impairment—Epirubicin—uterine cancer	0.000491	0.0014	CcSEcCtD
Clobazam—Erythema multiforme—Epirubicin—uterine cancer	0.000482	0.00137	CcSEcCtD
Clobazam—SLC6A11—NRF2 pathway—GPX3—uterine cancer	0.000477	0.0344	CbGpPWpGaD
Clobazam—Eye disorder—Epirubicin—uterine cancer	0.000476	0.00136	CcSEcCtD
Clobazam—Asthenia—Etoposide—uterine cancer	0.000463	0.00132	CcSEcCtD
Clobazam—Pruritus—Etoposide—uterine cancer	0.000457	0.0013	CcSEcCtD
Clobazam—Visual impairment—Doxorubicin—uterine cancer	0.000454	0.00129	CcSEcCtD
Clobazam—Mental disorder—Epirubicin—uterine cancer	0.000446	0.00127	CcSEcCtD
Clobazam—Erythema multiforme—Doxorubicin—uterine cancer	0.000446	0.00127	CcSEcCtD
Clobazam—Malnutrition—Epirubicin—uterine cancer	0.000443	0.00126	CcSEcCtD
Clobazam—Diarrhoea—Etoposide—uterine cancer	0.000442	0.00126	CcSEcCtD
Clobazam—SLC6A11—Neuronal System—ABCC9—uterine cancer	0.000441	0.0318	CbGpPWpGaD
Clobazam—Eye disorder—Doxorubicin—uterine cancer	0.00044	0.00125	CcSEcCtD
Clobazam—Tension—Epirubicin—uterine cancer	0.000435	0.00124	CcSEcCtD
Clobazam—Nervousness—Epirubicin—uterine cancer	0.000431	0.00123	CcSEcCtD
Clobazam—Dizziness—Etoposide—uterine cancer	0.000427	0.00122	CcSEcCtD
Clobazam—Muscle spasms—Epirubicin—uterine cancer	0.000426	0.00121	CcSEcCtD
Clobazam—Vision blurred—Epirubicin—uterine cancer	0.000418	0.00119	CcSEcCtD
Clobazam—Mental disorder—Doxorubicin—uterine cancer	0.000413	0.00118	CcSEcCtD
Clobazam—Vomiting—Etoposide—uterine cancer	0.000411	0.00117	CcSEcCtD
Clobazam—Malnutrition—Doxorubicin—uterine cancer	0.00041	0.00117	CcSEcCtD
Clobazam—Anaemia—Epirubicin—uterine cancer	0.00041	0.00117	CcSEcCtD
Clobazam—Agitation—Epirubicin—uterine cancer	0.000408	0.00116	CcSEcCtD
Clobazam—Rash—Etoposide—uterine cancer	0.000407	0.00116	CcSEcCtD
Clobazam—Dermatitis—Etoposide—uterine cancer	0.000407	0.00116	CcSEcCtD
Clobazam—Headache—Etoposide—uterine cancer	0.000404	0.00115	CcSEcCtD
Clobazam—SLC6A1—NRF2 pathway—NFE2L2—uterine cancer	0.000403	0.0291	CbGpPWpGaD
Clobazam—Tension—Doxorubicin—uterine cancer	0.000403	0.00115	CcSEcCtD
Clobazam—Nervousness—Doxorubicin—uterine cancer	0.000399	0.00113	CcSEcCtD
Clobazam—Leukopenia—Epirubicin—uterine cancer	0.000397	0.00113	CcSEcCtD
Clobazam—Muscle spasms—Doxorubicin—uterine cancer	0.000394	0.00112	CcSEcCtD
Clobazam—Cough—Epirubicin—uterine cancer	0.000387	0.0011	CcSEcCtD
Clobazam—Vision blurred—Doxorubicin—uterine cancer	0.000387	0.0011	CcSEcCtD
Clobazam—SLC6A1—NRF2 pathway—GPX3—uterine cancer	0.000384	0.0278	CbGpPWpGaD
Clobazam—Nausea—Etoposide—uterine cancer	0.000384	0.00109	CcSEcCtD
Clobazam—Anaemia—Doxorubicin—uterine cancer	0.000379	0.00108	CcSEcCtD
Clobazam—Myalgia—Epirubicin—uterine cancer	0.000378	0.00108	CcSEcCtD
Clobazam—Agitation—Doxorubicin—uterine cancer	0.000377	0.00107	CcSEcCtD
Clobazam—Anxiety—Epirubicin—uterine cancer	0.000376	0.00107	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000375	0.00107	CcSEcCtD
Clobazam—Dry mouth—Epirubicin—uterine cancer	0.000369	0.00105	CcSEcCtD
Clobazam—Leukopenia—Doxorubicin—uterine cancer	0.000367	0.00105	CcSEcCtD
Clobazam—Confusional state—Epirubicin—uterine cancer	0.000365	0.00104	CcSEcCtD
Clobazam—Infection—Epirubicin—uterine cancer	0.00036	0.00102	CcSEcCtD
Clobazam—Cough—Doxorubicin—uterine cancer	0.000358	0.00102	CcSEcCtD
Clobazam—SLC6A1—Neuronal System—ABCC9—uterine cancer	0.000355	0.0257	CbGpPWpGaD
Clobazam—Nervous system disorder—Epirubicin—uterine cancer	0.000355	0.00101	CcSEcCtD
Clobazam—Thrombocytopenia—Epirubicin—uterine cancer	0.000354	0.00101	CcSEcCtD
Clobazam—Skin disorder—Epirubicin—uterine cancer	0.000352	0.001	CcSEcCtD
Clobazam—Hyperhidrosis—Epirubicin—uterine cancer	0.00035	0.000996	CcSEcCtD
Clobazam—Myalgia—Doxorubicin—uterine cancer	0.000349	0.000995	CcSEcCtD
Clobazam—Anxiety—Doxorubicin—uterine cancer	0.000348	0.000991	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000347	0.000988	CcSEcCtD
Clobazam—Anorexia—Epirubicin—uterine cancer	0.000345	0.000982	CcSEcCtD
Clobazam—Dry mouth—Doxorubicin—uterine cancer	0.000342	0.000973	CcSEcCtD
Clobazam—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.00034	0.0246	CbGpPWpGaD
Clobazam—Hypotension—Epirubicin—uterine cancer	0.000338	0.000963	CcSEcCtD
Clobazam—Confusional state—Doxorubicin—uterine cancer	0.000338	0.000962	CcSEcCtD
Clobazam—Infection—Doxorubicin—uterine cancer	0.000333	0.000947	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00033	0.000939	CcSEcCtD
Clobazam—Nervous system disorder—Doxorubicin—uterine cancer	0.000328	0.000935	CcSEcCtD
Clobazam—Thrombocytopenia—Doxorubicin—uterine cancer	0.000328	0.000934	CcSEcCtD
Clobazam—Insomnia—Epirubicin—uterine cancer	0.000327	0.000932	CcSEcCtD
Clobazam—Skin disorder—Doxorubicin—uterine cancer	0.000325	0.000926	CcSEcCtD
Clobazam—Hyperhidrosis—Doxorubicin—uterine cancer	0.000324	0.000922	CcSEcCtD
Clobazam—Somnolence—Epirubicin—uterine cancer	0.000322	0.000916	CcSEcCtD
Clobazam—Anorexia—Doxorubicin—uterine cancer	0.000319	0.000909	CcSEcCtD
Clobazam—Decreased appetite—Epirubicin—uterine cancer	0.000315	0.000896	CcSEcCtD
Clobazam—Hypotension—Doxorubicin—uterine cancer	0.000313	0.000891	CcSEcCtD
Clobazam—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000312	0.00089	CcSEcCtD
Clobazam—Fatigue—Epirubicin—uterine cancer	0.000312	0.000889	CcSEcCtD
Clobazam—Constipation—Epirubicin—uterine cancer	0.000309	0.000881	CcSEcCtD
Clobazam—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000305	0.000869	CcSEcCtD
Clobazam—Insomnia—Doxorubicin—uterine cancer	0.000303	0.000863	CcSEcCtD
Clobazam—Feeling abnormal—Epirubicin—uterine cancer	0.000298	0.000849	CcSEcCtD
Clobazam—Somnolence—Doxorubicin—uterine cancer	0.000298	0.000848	CcSEcCtD
Clobazam—Decreased appetite—Doxorubicin—uterine cancer	0.000291	0.000829	CcSEcCtD
Clobazam—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000289	0.000823	CcSEcCtD
Clobazam—Fatigue—Doxorubicin—uterine cancer	0.000289	0.000822	CcSEcCtD
Clobazam—Urticaria—Epirubicin—uterine cancer	0.000288	0.000819	CcSEcCtD
Clobazam—Constipation—Doxorubicin—uterine cancer	0.000286	0.000816	CcSEcCtD
Clobazam—Body temperature increased—Epirubicin—uterine cancer	0.000286	0.000815	CcSEcCtD
Clobazam—Feeling abnormal—Doxorubicin—uterine cancer	0.000276	0.000786	CcSEcCtD
Clobazam—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000272	0.0196	CbGpPWpGaD
Clobazam—CYP2C18—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000269	0.0194	CbGpPWpGaD
Clobazam—Urticaria—Doxorubicin—uterine cancer	0.000266	0.000758	CcSEcCtD
Clobazam—Body temperature increased—Doxorubicin—uterine cancer	0.000265	0.000754	CcSEcCtD
Clobazam—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000262	0.0189	CbGpPWpGaD
Clobazam—Asthenia—Epirubicin—uterine cancer	0.00026	0.00074	CcSEcCtD
Clobazam—Pruritus—Epirubicin—uterine cancer	0.000256	0.000729	CcSEcCtD
Clobazam—ABCB1—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.000248	0.0179	CbGpPWpGaD
Clobazam—Diarrhoea—Epirubicin—uterine cancer	0.000248	0.000705	CcSEcCtD
Clobazam—CYP2C18—Tryptophan metabolism—CYP19A1—uterine cancer	0.000248	0.0179	CbGpPWpGaD
Clobazam—Asthenia—Doxorubicin—uterine cancer	0.00024	0.000684	CcSEcCtD
Clobazam—Dizziness—Epirubicin—uterine cancer	0.000239	0.000682	CcSEcCtD
Clobazam—SLC6A11—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000237	0.0171	CbGpPWpGaD
Clobazam—Pruritus—Doxorubicin—uterine cancer	0.000237	0.000675	CcSEcCtD
Clobazam—Vomiting—Epirubicin—uterine cancer	0.00023	0.000655	CcSEcCtD
Clobazam—Diarrhoea—Doxorubicin—uterine cancer	0.000229	0.000653	CcSEcCtD
Clobazam—Rash—Epirubicin—uterine cancer	0.000228	0.00065	CcSEcCtD
Clobazam—Dermatitis—Epirubicin—uterine cancer	0.000228	0.000649	CcSEcCtD
Clobazam—Headache—Epirubicin—uterine cancer	0.000227	0.000646	CcSEcCtD
Clobazam—Dizziness—Doxorubicin—uterine cancer	0.000221	0.000631	CcSEcCtD
Clobazam—CYP2C18—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000221	0.0159	CbGpPWpGaD
Clobazam—Nausea—Epirubicin—uterine cancer	0.000215	0.000612	CcSEcCtD
Clobazam—Vomiting—Doxorubicin—uterine cancer	0.000213	0.000606	CcSEcCtD
Clobazam—Rash—Doxorubicin—uterine cancer	0.000211	0.000601	CcSEcCtD
Clobazam—Dermatitis—Doxorubicin—uterine cancer	0.000211	0.000601	CcSEcCtD
Clobazam—Headache—Doxorubicin—uterine cancer	0.00021	0.000597	CcSEcCtD
Clobazam—CYP2C18—Metapathway biotransformation—AKR1B10—uterine cancer	0.000208	0.015	CbGpPWpGaD
Clobazam—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.0002	0.0145	CbGpPWpGaD
Clobazam—Nausea—Doxorubicin—uterine cancer	0.000199	0.000566	CcSEcCtD
Clobazam—CYP2C18—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000198	0.0143	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—AKR1B1—uterine cancer	0.000193	0.0139	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000191	0.0138	CbGpPWpGaD
Clobazam—CYP2C18—FOXA1 transcription factor network—ESR1—uterine cancer	0.000171	0.0124	CbGpPWpGaD
Clobazam—CYP2C18—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000162	0.0117	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—NDUFB11—uterine cancer	0.000154	0.0111	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—SRD5A2—uterine cancer	0.000154	0.0111	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—AKR1C1—uterine cancer	0.000142	0.0102	CbGpPWpGaD
Clobazam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000134	0.00966	CbGpPWpGaD
Clobazam—CYP2B6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000132	0.00953	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—GPX3—uterine cancer	0.000124	0.00899	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—ABCC9—uterine cancer	0.00012	0.00868	CbGpPWpGaD
Clobazam—CYP2C18—Biological oxidations—CYP11A1—uterine cancer	0.000117	0.00846	CbGpPWpGaD
Clobazam—CYP2C18—FOXA1 transcription factor network—CDKN1B—uterine cancer	0.000116	0.00841	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—CYP11A1—uterine cancer	0.000116	0.00834	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—AKR1B1—uterine cancer	0.000111	0.00802	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—STAR—uterine cancer	0.000111	0.00802	CbGpPWpGaD
Clobazam—CYP2C19—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.00011	0.00798	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—ABCC9—uterine cancer	0.00011	0.00794	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—AKR1C3—uterine cancer	0.000109	0.00788	CbGpPWpGaD
Clobazam—CYP2B6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000108	0.00783	CbGpPWpGaD
Clobazam—CYP2C18—FOXA1 transcription factor network—EP300—uterine cancer	0.000102	0.00739	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—AKR1B10—uterine cancer	0.000102	0.00738	CbGpPWpGaD
Clobazam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000101	0.0073	CbGpPWpGaD
Clobazam—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	9.98e-05	0.0072	CbGpPWpGaD
Clobazam—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	9.84e-05	0.00711	CbGpPWpGaD
Clobazam—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	9.71e-05	0.00701	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—ABCC9—uterine cancer	9.61e-05	0.00694	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	9.53e-05	0.00688	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—AKR1B1—uterine cancer	9.5e-05	0.00686	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—POLD1—uterine cancer	8.71e-05	0.00629	CbGpPWpGaD
Clobazam—CYP2C18—Biological oxidations—CYP19A1—uterine cancer	8.62e-05	0.00623	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—CYP19A1—uterine cancer	8.5e-05	0.00614	CbGpPWpGaD
Clobazam—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	8.2e-05	0.00592	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—AKR1C1—uterine cancer	8.15e-05	0.00588	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	8.04e-05	0.00581	CbGpPWpGaD
Clobazam—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.98e-05	0.00576	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	7.72e-05	0.00557	CbGpPWpGaD
Clobazam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	7.44e-05	0.00537	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—ESR2—uterine cancer	7.42e-05	0.00536	CbGpPWpGaD
Clobazam—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	7.34e-05	0.0053	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—RRM2—uterine cancer	7.26e-05	0.00524	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	7.18e-05	0.00518	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—DCN—uterine cancer	7.05e-05	0.00509	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—AKR1C1—uterine cancer	6.97e-05	0.00503	CbGpPWpGaD
Clobazam—SLC6A11—Transmission across Chemical Synapses—HRAS—uterine cancer	6.91e-05	0.00499	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CYP11A1—uterine cancer	6.64e-05	0.0048	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.47e-05	0.00467	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—AKR1C3—uterine cancer	6.27e-05	0.00453	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—GPX3—uterine cancer	6.12e-05	0.00442	CbGpPWpGaD
Clobazam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	6.08e-05	0.00439	CbGpPWpGaD
Clobazam—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.03e-05	0.00435	CbGpPWpGaD
Clobazam—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	6e-05	0.00433	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.91e-05	0.00427	CbGpPWpGaD
Clobazam—CYP2B6—Biological oxidations—CYP11A1—uterine cancer	5.76e-05	0.00416	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—CYP11A1—uterine cancer	5.68e-05	0.0041	CbGpPWpGaD
Clobazam—SLC6A1—Transmission across Chemical Synapses—HRAS—uterine cancer	5.57e-05	0.00402	CbGpPWpGaD
Clobazam—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	5.53e-05	0.00399	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	5.51e-05	0.00398	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	5.37e-05	0.00387	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	5.32e-05	0.00384	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—HRAS—uterine cancer	5.29e-05	0.00382	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	5.27e-05	0.0038	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—ABCC9—uterine cancer	5.17e-05	0.00373	CbGpPWpGaD
Clobazam—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	4.93e-05	0.00356	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CYP19A1—uterine cancer	4.89e-05	0.00353	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—STK11—uterine cancer	4.89e-05	0.00353	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	4.64e-05	0.00335	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—NDUFB11—uterine cancer	4.63e-05	0.00334	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—SRD5A2—uterine cancer	4.63e-05	0.00334	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	4.62e-05	0.00334	CbGpPWpGaD
Clobazam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	4.47e-05	0.00323	CbGpPWpGaD
Clobazam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	4.41e-05	0.00319	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	4.35e-05	0.00314	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	4.31e-05	0.00312	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	4.29e-05	0.0031	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—HRAS—uterine cancer	4.27e-05	0.00308	CbGpPWpGaD
Clobazam—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	4.24e-05	0.00306	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	4.18e-05	0.00302	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	4.05e-05	0.00293	CbGpPWpGaD
Clobazam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	3.88e-05	0.0028	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.86e-05	0.00279	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—MTHFR—uterine cancer	3.67e-05	0.00265	CbGpPWpGaD
Clobazam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.63e-05	0.00262	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	3.42e-05	0.00247	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—STAR—uterine cancer	3.35e-05	0.00242	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—AKR1B1—uterine cancer	3.35e-05	0.00242	CbGpPWpGaD
Clobazam—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	3.2e-05	0.00231	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.17e-05	0.00229	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	3.17e-05	0.00229	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	3.16e-05	0.00228	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	3.13e-05	0.00226	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	2.89e-05	0.00209	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.87e-05	0.00208	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.79e-05	0.00202	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.79e-05	0.00202	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.78e-05	0.00201	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CXCL8—uterine cancer	2.71e-05	0.00196	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—EP300—uterine cancer	2.69e-05	0.00194	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	2.68e-05	0.00194	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—POLD1—uterine cancer	2.63e-05	0.0019	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.62e-05	0.00189	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.59e-05	0.00187	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.58e-05	0.00186	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.58e-05	0.00186	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	2.54e-05	0.00184	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.54e-05	0.00183	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.51e-05	0.00181	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—AKR1C1—uterine cancer	2.46e-05	0.00178	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.44e-05	0.00176	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.29e-05	0.00166	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—SRD5A2—uterine cancer	2.28e-05	0.00164	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—NDUFB11—uterine cancer	2.28e-05	0.00164	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.2e-05	0.00159	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—RRM2—uterine cancer	2.19e-05	0.00158	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—DCN—uterine cancer	2.13e-05	0.00154	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.05e-05	0.00148	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PTEN—uterine cancer	2.04e-05	0.00148	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2e-05	0.00145	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CYP11A1—uterine cancer	2e-05	0.00145	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—EP300—uterine cancer	1.95e-05	0.00141	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.93e-05	0.00139	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.92e-05	0.00139	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.9e-05	0.00137	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—AKR1C3—uterine cancer	1.89e-05	0.00137	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—HRAS—uterine cancer	1.89e-05	0.00136	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—HRAS—uterine cancer	1.72e-05	0.00125	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.72e-05	0.00124	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.72e-05	0.00124	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—NDUFB11—uterine cancer	1.68e-05	0.00121	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—SRD5A2—uterine cancer	1.68e-05	0.00121	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.67e-05	0.00121	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—STAR—uterine cancer	1.65e-05	0.00119	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—AKR1B1—uterine cancer	1.65e-05	0.00119	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.62e-05	0.00117	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.58e-05	0.00114	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—HRAS—uterine cancer	1.51e-05	0.00109	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—STK11—uterine cancer	1.47e-05	0.00106	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CYP19A1—uterine cancer	1.47e-05	0.00106	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—HRAS—uterine cancer	1.44e-05	0.00104	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PIK3CA—uterine cancer	1.44e-05	0.00104	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.41e-05	0.00102	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—HRAS—uterine cancer	1.32e-05	0.000954	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.31e-05	0.000942	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—POLD1—uterine cancer	1.29e-05	0.000933	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.24e-05	0.000898	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—STAR—uterine cancer	1.24e-05	0.000898	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.23e-05	0.00089	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.23e-05	0.000888	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—AKR1B1—uterine cancer	1.21e-05	0.000877	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—STAR—uterine cancer	1.21e-05	0.000877	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.21e-05	0.000873	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.2e-05	0.000868	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—AKT1—uterine cancer	1.18e-05	0.00085	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—HRAS—uterine cancer	1.15e-05	0.000834	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.15e-05	0.000828	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—MTHFR—uterine cancer	1.11e-05	0.0008	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.09e-05	0.000784	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—RRM2—uterine cancer	1.08e-05	0.000778	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—DCN—uterine cancer	1.05e-05	0.000755	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.03e-05	0.000747	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.03e-05	0.000747	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CYP11A1—uterine cancer	9.85e-06	0.000711	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—POLD1—uterine cancer	9.76e-06	0.000705	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—POLD1—uterine cancer	9.53e-06	0.000688	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—AKR1C3—uterine cancer	9.3e-06	0.000672	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.23e-06	0.000666	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—AKR1C1—uterine cancer	9.13e-06	0.000659	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—AKR1C1—uterine cancer	8.91e-06	0.000644	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.48e-06	0.000612	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.2e-06	0.000592	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—RRM2—uterine cancer	8.14e-06	0.000588	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—RRM2—uterine cancer	7.94e-06	0.000574	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—DCN—uterine cancer	7.9e-06	0.000571	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—DCN—uterine cancer	7.71e-06	0.000557	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—STAR—uterine cancer	7.48e-06	0.00054	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—AKR1B1—uterine cancer	7.48e-06	0.00054	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CYP11A1—uterine cancer	7.44e-06	0.000538	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CYP11A1—uterine cancer	7.27e-06	0.000525	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CYP19A1—uterine cancer	7.25e-06	0.000523	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—STK11—uterine cancer	7.25e-06	0.000523	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—AKR1C3—uterine cancer	7.03e-06	0.000508	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.93e-06	0.0005	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—AKR1C3—uterine cancer	6.86e-06	0.000496	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PTEN—uterine cancer	6.16e-06	0.000445	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—EP300—uterine cancer	5.88e-06	0.000424	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—POLD1—uterine cancer	5.87e-06	0.000424	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—AKR1C1—uterine cancer	5.49e-06	0.000397	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CYP19A1—uterine cancer	5.48e-06	0.000396	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—STK11—uterine cancer	5.48e-06	0.000396	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—MTHFR—uterine cancer	5.45e-06	0.000393	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—STK11—uterine cancer	5.35e-06	0.000386	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CYP19A1—uterine cancer	5.35e-06	0.000386	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.14e-06	0.000371	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.9e-06	0.000354	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—RRM2—uterine cancer	4.89e-06	0.000353	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—DCN—uterine cancer	4.75e-06	0.000343	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.48e-06	0.000323	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PIK3CA—uterine cancer	4.35e-06	0.000314	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.23e-06	0.000305	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—MTHFR—uterine cancer	4.12e-06	0.000297	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—MTHFR—uterine cancer	4.02e-06	0.00029	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.63e-06	0.000262	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—AKT1—uterine cancer	3.55e-06	0.000256	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.29e-06	0.000238	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—STK11—uterine cancer	3.29e-06	0.000238	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PTEN—uterine cancer	3.03e-06	0.000219	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—EP300—uterine cancer	2.89e-06	0.000209	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—MTHFR—uterine cancer	2.48e-06	0.000179	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PTEN—uterine cancer	2.29e-06	0.000165	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PTEN—uterine cancer	2.23e-06	0.000161	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—EP300—uterine cancer	2.18e-06	0.000158	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.14e-06	0.000154	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—EP300—uterine cancer	2.13e-06	0.000154	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—AKT1—uterine cancer	1.75e-06	0.000126	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.62e-06	0.000117	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PIK3CA—uterine cancer	1.58e-06	0.000114	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PTEN—uterine cancer	1.38e-06	9.94e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—AKT1—uterine cancer	1.32e-06	9.53e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—EP300—uterine cancer	1.31e-06	9.48e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—AKT1—uterine cancer	1.29e-06	9.3e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PIK3CA—uterine cancer	9.71e-07	7.01e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—AKT1—uterine cancer	7.94e-07	5.73e-05	CbGpPWpGaD
